EUR 1.24
(-2.97%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.55 Million EUR | 13.42% |
2022 | 2.25 Million EUR | 99.56% |
2021 | 1.12 Million EUR | 187.02% |
2020 | 393 Thousand EUR | -17.09% |
2019 | 474 Thousand EUR | -27.96% |
2018 | 658 Thousand EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 2.73 Million EUR | 2.2% |
2024 Q1 | 2.68 Million EUR | 5.29% |
2024 Q2 | 2.67 Million EUR | -0.37% |
2023 Q3 | 2.55 Million EUR | 0.91% |
2023 FY | 2.55 Million EUR | 13.42% |
2023 Q4 | 2.55 Million EUR | 0.0% |
2023 Q2 | 2.53 Million EUR | 0.0% |
2023 Q1 | - EUR | -100.0% |
2022 Q2 | 1.97 Million EUR | 0.0% |
2022 FY | 2.25 Million EUR | 99.56% |
2022 Q4 | 2.25 Million EUR | 0.0% |
2022 Q3 | 2.25 Million EUR | 13.97% |
2022 Q1 | - EUR | -100.0% |
2021 Q4 | 1.12 Million EUR | 0.0% |
2021 Q1 | - EUR | -100.0% |
2021 FY | 1.12 Million EUR | 187.02% |
2021 Q2 | 576 Thousand EUR | 0.0% |
2021 Q3 | 1.12 Million EUR | 95.83% |
2020 FY | 393 Thousand EUR | -17.09% |
2020 Q4 | 393 Thousand EUR | 0.0% |
2019 FY | 474 Thousand EUR | -27.96% |
2018 FY | 658 Thousand EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | 1.97 Million EUR | -29.594% |
Nexstim Plc | 1.04 Million EUR | -144.4% |
Revenio Group Oyj | 10.5 Million EUR | 75.686% |